These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17536975)

  • 1. In vivo selection and chemoprotection after drug resistance gene therapy in a nonmyeloablative allogeneic transplantation setting in dogs.
    Gerull S; Beard BC; Peterson LJ; Neff T; Kiem HP
    Hum Gene Ther; 2007 May; 18(5):451-6. PubMed ID: 17536975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of a P140K mutant O6-methylguanine-DNA-methyltransferase (MGMT)-expressing transgenic mouse line with drug-selectable bone marrow.
    Kramer BA; Lemckert FA; Alexander IE; Gunning PW; McCowage GB
    J Gene Med; 2006 Sep; 8(9):1071-85. PubMed ID: 16927363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.
    Neff T; Horn PA; Peterson LJ; Thomasson BM; Thompson J; Williams DA; Schmidt M; Georges GE; von Kalle C; Kiem HP
    J Clin Invest; 2003 Nov; 112(10):1581-8. PubMed ID: 14617759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy.
    Neff T; Beard BC; Peterson LJ; Anandakumar P; Thompson J; Kiem HP
    Blood; 2005 Feb; 105(3):997-1002. PubMed ID: 15494421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression.
    Falahati R; Zhang J; Flebbe-Rehwaldt L; Shi Y; Gerson SL; Gaensler KM
    Mol Ther; 2012 Nov; 20(11):2180-9. PubMed ID: 22871662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression of canine O6-methylguanine-DNA methyltransferase in target cells, using gammaretroviral and lentiviral vectors.
    Zaboikin M; Srinivasakumar N; Zaboikina T; Schuening F
    Hum Gene Ther; 2004 Apr; 15(4):383-92. PubMed ID: 15053863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term polyclonal and multilineage engraftment of methylguanine methyltransferase P140K gene-modified dog hematopoietic cells in primary and secondary recipients.
    Beard BC; Sud R; Keyser KA; Ironside C; Neff T; Gerull S; Trobridge GD; Kiem HP
    Blood; 2009 May; 113(21):5094-103. PubMed ID: 19336761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection.
    Richard E; Robert E; Cario-André M; Ged C; Géronimi F; Gerson SL; de Verneuil H; Moreau-Gaudry F
    Gene Ther; 2004 Nov; 11(22):1638-47. PubMed ID: 15284838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantation.
    Hacke K; Falahati R; Flebbe-Rehwaldt L; Kasahara N; Gaensler KM
    Immunol Res; 2009; 44(1-3):112-26. PubMed ID: 19048410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived cells exhibiting lung epithelial cell characteristics are enriched in vivo using methylguanine DNA methyltransferase-mediated drug resistance.
    Reese JS; Roth JC; Gerson SL
    Stem Cells; 2008 Mar; 26(3):675-81. PubMed ID: 18192231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell lines.
    Richard E; Géronimi F; Lalanne M; Ged C; Redonnet-Vernhet I; Lamrissi-Garcia I; Gerson SL; de Verneuil H; Moreau-Gaudry F
    J Gene Med; 2003 Sep; 5(9):737-47. PubMed ID: 12950064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations.
    Pollok KE; Hartwell JR; Braber A; Cooper RJ; Jansen M; Ragg S; Bailey BJ; Erickson LC; Kreklau EL; Williams DA
    Hum Gene Ther; 2003 Dec; 14(18):1703-14. PubMed ID: 14670122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
    Au WY; Lie AK; Siu LL; Chan EC; Ooi GC; Leung AY; Liang R; Kwong YL
    Ann Hematol; 2003 Sep; 82(9):548-51. PubMed ID: 14504811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transduction and amplification in large animal models.
    Trobridge G; Beard BC; Kiem HP
    Hum Gene Ther; 2005 Dec; 16(12):1355-66. PubMed ID: 16390267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.